Vium Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 51

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.6M

Vium General Information

Description

Provider of digital biomarkers intended to assist in pre-clinical drug research. The company's biomarkers are derived from artificial intelligence, machine learning and sensor technology and assists in accelerating the pre-clinical drug discovery and development pipeline, enabling researchers and drug developers to obtain improved insights into disease progression and take better decisions on which compounds should be advanced to the clinic.

Contact Information

Website
www.vium.com
Formerly Known As
Mousera
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 411 Borel Place
  • Suite 616
  • San Mateo, CA 94402
  • United States
+1 (650)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Other Healthcare Technology Systems
Biotechnology
Parent Company
Vertical(s)
Artificial Intelligence & Machine Learning, TMT, Life Sciences
Corporate Office
  • 411 Borel Place
  • Suite 616
  • San Mateo, CA 94402
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vium Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 28-Jul-2020 $2.6M Completed Generating Revenue
5. Debt - PPP 13-Apr-2020 Completed Generating Revenue
4. Early Stage VC (Series B) 21-Jun-2018 Completed Generating Revenue
3. Early Stage VC (Series A) 09-Jun-2015 Completed Generating Revenue
2. Early Stage VC (Series A1) 28-Oct-2014 $8.8M $9.9M Completed Generating Revenue
1. Seed Round 24-Mar-2014 $1.14M $1.14M Completed Startup
To view Vium’s complete valuation and funding history, request access »

Vium Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A4
Series A3
Series A2 283,128 $0.000100 8% $2.26 $2.26 1x $2.26 2.21%
Series A1 3,132,184 $0.000100 8% $2.83 $2.83 1x $2.83 24.29%
To view Vium’s complete cap table history, request access »

Vium Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of digital biomarkers intended to assist in pre-clinical drug research. The company's biomarkers are derived fr
Discovery Tools (Healthcare)
San Mateo, CA
51 As of 2016

Villigen, Switzerland
 

San Leandro, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vium Competitors (5)

One of Vium’s 5 competitors is InterAx, a Venture Capital-Backed company based in Villigen, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InterAx Venture Capital-Backed Villigen, Switzerland
Tierra (Discovery Tools (Healthcare)) Venture Capital-Backed San Leandro, CA
XtalPi Technology Formerly VC-backed Shenzhen, China
Kymera Therapeutics Formerly VC-backed Watertown, MA
CrossBeta Biosciences Formerly VC-backed Utrecht, Netherlands
You’re viewing 5 of 5 competitors. Get the full list »

Vium Patents

Vium Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190191665-A1 System and method of measured drug efficacy using non-invasive testing Inactive 21-Dec-2017
US-10789432-B2 Tracklets Active 20-Dec-2017
US-20190188425-A1 Tracklets Active 20-Dec-2017
US-10463017-B2 Device and method for multi-dimensional classification of rodent vocalizations Active 03-Aug-2017
US-20190037801-A1 Device and method for multi-dimensional classification of rodent vocalizations Active 03-Aug-2017 A01K1/031
To view Vium’s complete patent history, request access »

Vium Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vium Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
AME Cloud Ventures Venture Capital Minority
Brad Murphy Angel (individual) Minority
Build Collective Venture Capital Minority
Christine McCaull Angel (individual) Minority
DCVC Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Vium FAQs

  • When was Vium founded?

    Vium was founded in 2013.

  • Where is Vium headquartered?

    Vium is headquartered in San Mateo, CA.

  • What is the size of Vium?

    Vium has 51 total employees.

  • What industry is Vium in?

    Vium’s primary industry is Discovery Tools (Healthcare).

  • Is Vium a private or public company?

    Vium is a Private company.

  • What is the current valuation of Vium?

    The current valuation of Vium is .

  • What is Vium’s current revenue?

    The current revenue for Vium is .

  • How much funding has Vium raised over time?

    Vium has raised $53.9M.

  • Who are Vium’s investors?

    AME Cloud Ventures, Brad Murphy, Build Collective, Christine McCaull, and DCVC are 5 of 10 investors who have invested in Vium.

  • Who are Vium’s competitors?

    InterAx, Tierra (Discovery Tools (Healthcare)), XtalPi Technology, Kymera Therapeutics, and CrossBeta Biosciences are competitors of Vium.

  • When was Vium acquired?

    Vium was acquired on 28-Jul-2020.

  • Who acquired Vium?

    Vium was acquired by Recursion Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »